Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial

INTRODUCTION: The effectiveness of umifenovir against COVID-19 is controversial; therefore, clinical trials are crucial to evaluate its efficacy. METHODS: The study was conducted as a single-center, randomized, open-label clinical trial. Eligible moderate-severe hospitalized patients with confirmed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunopharmacol
Main Authors: Alavi Darazam, Ilad, Shokouhi, Shervin, Mardani, Masoud, Pourhoseingholi, Mohamad Amin, Rabiei, Mohammad Mahdi, Hatami, Firouze, Shabani, Minoosh, Moradi, Omid, Gharehbagh, Farid Javandoust, Irvani, Seyed Sina Naghibi, Amirdosara, Mahdi, Hajiesmaeili, Mohammadreza, Rezaei, Omidvar, Khoshkar, Ali, Lotfollahi, Legha, Gachkar, Latif, Dehbsneh, Hadiseh Shabanpour, Khalili, Negar, Soleymaninia, Azam, Kusha, Akram Hoseyni, Shoushtari, Maryam Taleb, Torabinavid, Parham
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270750/
https://ncbi.nlm.nih.gov/pubmed/34273635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107969
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados